Search

everythinglearnresearchcommunity

for

Search:↓

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

A new gene mutation causes insulin resistance in a girl and her mother.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Skin symptoms can indicate endocrine disorders and have various treatments.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Lower SHBG levels may increase the risk of PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.